buyers v sellers, page-21

megles-You sound like someone from Medpro who is upset that you lost the UNI deal. Is that the reason for your down talking?

I wouldn't take 70 cents and give up the SA potential. UNI will not need additional funds with the SA deal in place.

There will be $16.4 million coming in on July 31, then another $2.4 million on September 30, with periodic payments from SA thereafter. Sounds like a very cash flow positive situation to me.

As to the share price, that will take care of itself. As UNI moves closer to first sales to SA and first sales of the Unitract syringe, investors will want to take part in the company's future growth. Sure, along the way, as now, there will be some ups and downs, but medium to long term the trend will be up. There will be adequate opportunity for both investors and traders to make money.